Scarica l'app Stockscreener
146.34
0.45%
0.66
Pre-mercato:
146.00
-0.34
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Gilead Sciences director Jeffrey Bluestone sells $725,077 in stock - Investing.com
Gilead Sciences director Jeffrey Bluestone sells $725,077 in stock By Investing.com - Investing.com UK
Gilead Sciences (NASDAQ:GILD) Director Sells 5,000 Shares of Stock - MarketBeat
Gilead Sciences (GILD) director sells 5,000 shares near $146 - Stock Titan
Portfolio Design Labs LLC Takes $1.29 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
PCM Encore LLC Buys Shares of 7,399 Gilead Sciences, Inc. $GILD - MarketBeat
Vise Technologies Inc. Takes $15.17 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
14,265 Shares in Gilead Sciences, Inc. $GILD Purchased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Trillium Asset Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Allworth Financial LP Invests $5.96 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Altman Advisors Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
B. Metzler seel. Sohn & Co. AG Purchases New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (NASDAQ: GILD) director to sell 5,000 shares in 2026 - Stock Titan
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Gilead Sciences Stock Surges 11%, With A 7-Day Winning Spree - Trefis
Gilead Sciences Stock Climbs 11% On A 7-Day Winning Streak - Trefis
Zacks Research Expects Higher Earnings for Gilead Sciences - MarketBeat
Westport Asset Management Inc. Acquires Shares of 10,000 Gilead Sciences, Inc. $GILD - MarketBeat
Johnson Financial Group Inc. Invests $2.12 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Tocqueville Asset Management L.P. Purchases Shares of 59,933 Gilead Sciences, Inc. $GILD - MarketBeat
NewEdge Wealth LLC Takes $95.26 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Knuff & Co LLC Buys Shares of 17,641 Gilead Sciences, Inc. $GILD - MarketBeat
E Fund Management Co. Ltd. Acquires Shares of 53,836 Gilead Sciences, Inc. $GILD - MarketBeat
Edmond DE Rothschild Holding S.A. Purchases New Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Great Lakes Advisors LLC Buys Shares of 62,450 Gilead Sciences, Inc. $GILD - MarketBeat
59,974 Shares in Gilead Sciences, Inc. $GILD Purchased by Abacus FCF Advisors LLC - MarketBeat
Foster & Motley Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Diversify Advisory Services LLC Invests $1.82 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Does Gilead (GILD) Pairing With Nucleai Reveal a Deeper Shift in Its Oncology Strategy? - Yahoo Finance
Gilead SciencesGISStock Price & News - The Motley Fool
Publicis wins Gilead Sciences' US media account - Ad Age
Gilead Sciences Inc Stock (GILD) Moved Up by 3.66% on Aug 19: A Full Analysis - TradingKey
Gilead Sciences (GILD) CFO Andrew Dickinson Sells 3,000 Shares - GuruFocus
Zacks Research Forecasts Higher Earnings for Gilead Sciences - MarketBeat
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Meeder Advisory Services Inc. Invests $4.42 Million in Gilead Sciences, Inc. $GILD - MarketBeat
M. Kulyk & Associates LLC Buys New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Pallas Capital Advisors LLC Invests $940,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Great Lakes Advisors LLC Makes New $127.25 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
13,735 Shares in Gilead Sciences, Inc. $GILD Purchased by Empirical Asset Management LLC - MarketBeat
840,400 Shares in Gilead Sciences, Inc. $GILD Purchased by Danske Bank A S - MarketBeat
Gilead Sciences Insider Sold Shares Worth $3,853,908, According to a Recent SEC Filing - marketscreener.com
Gilead Sciences CFO Andrew Dickinson sells $415k in shares - Investing.com
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences chief comm & corp aff officer sells $3.85m stock - Investing.com
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 28,000 Shares of Stock - MarketBeat
Gilead (NASDAQ: GILD) CFO sells shares under 10b5-1 plan - Stock Titan
Gilead (NASDAQ: GILD) CCO sells 28,000 shares under 10b5-1 plan - Stock Titan
Gilead Sciences Inc (GILD) Stock Up 3.2% but GF Value Says Overv - GuruFocus
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Is Gilead's Expanding HIV Portfolio a Growth Catalyst? - TradingView
Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement - TradingKey
Gilead gains as investors focus on stronger HIV momentum and a near-term FDA catalyst - Quiver Quantitative
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited. - AOL.com
Texas Capital Bank Wealth Management Services Inc Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Meeder Asset Management Inc. Invests $17.12 Million in Gilead Sciences, Inc. $GILD - MarketBeat
34,701 Shares in Gilead Sciences, Inc. $GILD Purchased by Occidental Asset Management LLC - MarketBeat
Perigon Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $398.90 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
21,689 Shares in Gilead Sciences, Inc. $GILD Purchased by Citizens Financial Group Inc. RI - MarketBeat
41,571 Shares in Gilead Sciences, Inc. $GILD Acquired by Commerzbank Aktiengesellschaft FI - MarketBeat
Grandfield & Dodd LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
GSA Capital Partners LLP Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
121,844,108 Shares in Gilead Sciences, Inc. $GILD Purchased by BlackRock Inc. - MarketBeat
Gilead Sciences Earnings Call Highlights Strong Core Growth - The Globe and Mail
TRADEMARK—4th Cir.: Gilead Sciences secures affirmance of injunction blocking foreign-market Biktarvy drug imports - VitalLaw.com
Gilead Sciences (NASDAQ: GILD) insider plans $3.9M share sale - Stock Titan
Gilead Sciences (NASDAQ: GILD) insider plans another 3,000-share sale - Stock Titan
Gilead yanks out a thorn in its side in major court ruling - Yahoo Finance Singapore
In Win for Gilead, Fourth Circuit Affirms Injunction Blocking Drug Importation Scheme - IPWatchdog.com
0.61%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):